CytomX Therapeutics (CTMX) Preferred Shares (2014 - 2015)
CytomX Therapeutics' Preferred Shares was $159.08 million in Q3 2015.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Preferred Shares (2014 - 2015) Analysis & Trends
At the end of FY2014, Preferred Shares at CytomX Therapeutics came in at $76.71 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - | - |
API Access
CytomX Therapeutics Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();